Next-Gen BioPharma Data Platform
Structured R&D Intelligence. Ready to Model. Ready to Move.
A robust set of data available for building prediction models:
Ticker Symbols
Products
Years of Data
Comprehensive Pharmaceutical and Biotech Data:
Disease Areas
Data Elements
Clinical Trials
Announcements & White Papers
Solutions We Provide:
A radically new competitive intelligence tool that cuts through data noise
Our free, real-time database of more than 600,000+ clinical trial records
Complete market scans across patents, white papers, clinical activity, and news
Future catalyst event dataset for the biopharma market
Discover drugs in development by disease, mechanism of action, or by country
Trusted sources for pre-clinical, clinical, & approved pharma
Ask Us How to Bring External Intelligence into Your Portfolio Strategy
Unify competitive intelligence with your internal portfolio using clean, machine-readable data aligned to your business vocabulary – tracking trial progression, competitive shifts, and strategic implications in real time.
About Us
OZMOSI was founded on the idea that today’s healthcare data can be better accessed, understood, and leveraged. We believe analytics – based on big data or small data – can support better business decisions.
Key Dates | Clinical Outcomes / PDUFA
Staying Ahead of the Headlines
Stay ahead of the headlines with our industry-leading catalyst event database. This comprehensive dataset includes future data readouts, enrollment goals, PDUFA dates, and IND filings. With coverage back to December 2023, over 3,000 events spanning approximately 700 tickers and 1,500 distinct products are covered.
Comprehensive Market Scans | Product One Pagers
Key One Pagers & Market Landscapes
PRYZM captures, assembles, and delivers all the pharmaceutical product data you need at your fingertips. Delivering the data you need for drugs in use and development worldwide. Using advanced analytics, we collect, refine, and index data from dozens of trusted sources worldwide for your pre-clinical, clinical, or approved pharmaceuticals in use worldwide.
NEW! Next-Gen Probability of Success for Each Development Stage
Our NEW probability of success measure is uncovering multiple industry trends that were never before available.
Contact us today to learn about how our success predictions are delivering accuracy rates of 70%-80%.
Get Started with OZMOSI
We synthesize and process insights, delivering what you need quickly, effectively, and efficiently.
600 Warren Ave,
Spring Lake, NJ 07762